Vanilloid receptor TRPV1 in drug discovery: targeting pain and other pathological disorders
Gomtsyan, Arthur
Faltynek, Connie R.
113,56 €(IVA inc.)
This book discusses recent advances in biology, chemistry, and pharmacology at both the preclinical and clinical stage of the dynamic area of TRPV1 drug discovery research. Chapters explore the impact and drug targeting of TRPV1 in pain areas like inflammation, migraine, arthritis, and cancer; as well as the development of analgesic drugs. The TRPV1 receptor is not limited to pain only,and the book also includes coverage of its role in respiratory disease and diabetes. The book features data relevant to therapeutic potential of TRPV1 and the medicinal chemistry involved in designing TRPV1 antagonists.
- ISBN: 978-0-470-17557-6
- Editorial: John Wiley & Sons
- Encuadernacion: Cartoné
- Páginas: 512
- Fecha Publicación: 19/02/2010
- Nº Volúmenes: 1
- Idioma: Inglés